| ADI | Acceptable Daily Intake |
| AhR | Aryl hydrocarbon Receptor |
| AR | Androgen Receptor |
| BC | Breast Cancer |
| BMI | Body Mass Index |
| BPA | Bisphenol A |
| BRCA1/2 | Breast Cancer type 1/2 susceptibility protein |
| DDE | Dichlorodiphenyldichloroethylene |
| DDT | Dichlorodiphenyltrichloroethane |
| DES | Diethylstilbestrol or stilbestrol |
| DNMTs | DNA methyltransferases |
| EDCs | Endocrine Disrupting Chemicals |
| EPA | Environmental Protection Agency |
| ERα/β | Estrogen Receptor α/β |
| ERE | Estrogen Response Elements |
| ERRγ | Estrogen-Related Receptor γ |
| FDA | Food and Drug Administration |
| GPR30 | G Protein-coupled Receptor 30 |
| HER2 | Human Epidermal Growth Factor Receptor 2 |
| HRT | Hormone Replacement Therapy |
| IARC | International Agency for Research on Cancer |
| LOAEL | Lowest Observed Adverse Effect Level |
| miRNA | microRNA |
| mRNA | messenger RNA |
| NOAEL | No Observable Adverse Effect Level |
| PDCD4 | Programmed Cell Death Protein 4 |
| POP | Persistent Organic Pollutant |
| PR | Progesterone Receptor |
| SR | Steroid Receptor |
| TCDD | 2,3,7,8-tetrachlorodibenzo-p-dioxin |
| TEB | Terminal End Buds |
| TEQ | Toxic Equivalent |
| TNBC | Triple Negative Breast Cancer |
| WHO | World Health Organization |